ONE Bio (OTCMKTS:ONBI) versus Canopy Growth (NASDAQ:CGC) Head to Head Review

ONE Bio (OTCMKTS:ONBIGet Rating) and Canopy Growth (NASDAQ:CGCGet Rating) are both basic materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, risk, dividends, institutional ownership and profitability.

Analyst Ratings

This is a breakdown of recent ratings for ONE Bio and Canopy Growth, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ONE Bio 0 0 0 0 N/A
Canopy Growth 6 5 2 0 1.69

Canopy Growth has a consensus price target of $5.28, suggesting a potential upside of 102.36%. Given Canopy Growth’s higher probable upside, analysts clearly believe Canopy Growth is more favorable than ONE Bio.

Risk & Volatility

ONE Bio has a beta of -5.56, suggesting that its share price is 656% less volatile than the S&P 500. Comparatively, Canopy Growth has a beta of 1.99, suggesting that its share price is 99% more volatile than the S&P 500.

Institutional and Insider Ownership

15.8% of Canopy Growth shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares ONE Bio and Canopy Growth’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ONE Bio N/A N/A N/A N/A N/A
Canopy Growth $415.09 million 3.11 -$241.08 million ($5.83) -0.45

ONE Bio has higher earnings, but lower revenue than Canopy Growth.

Profitability

This table compares ONE Bio and Canopy Growth’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ONE Bio N/A N/A N/A
Canopy Growth -621.80% -30.28% -17.73%

Summary

Canopy Growth beats ONE Bio on 6 of the 9 factors compared between the two stocks.

About ONE Bio

(Get Rating)

One Bio Corp. engages in the utilization of green processes to produce raw chemicals and herbal extracts, natural supplements, and organic products. The company was founded on June 30, 2000 and is headquartered in Aventura, FL.

About Canopy Growth

(Get Rating)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Receive News & Ratings for ONE Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ONE Bio and related companies with MarketBeat.com's FREE daily email newsletter.